Food science & nutrition
Cure8 research brief
Why This Matters
This preclinical work suggests the gut microbiota and tryptophan-derived metabolites that activate AhR may be important in reducing colitis-related inflammation — a potential route for future therapies relevant to ulcerative colitis and other IBD forms.
If microbiota-dependent herbal or metabolite-based approaches prove effective in humans, they could offer new, non-biologic treatment strategies or adjuncts to existing therapies.
Who Should Pay Attention
Researchers studying IBD biology, microbiome therapeutics, and AhR signaling; clinicians interested in emerging preclinical mechanisms for UC; patients curious about microbiome-targeted experimental approaches (not clinical recommendations).
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This study (abstract) reports that Baitouweng Tang (BTWT), a traditional herbal formula, reduced colitis severity in mouse models by altering the gut microbiota and increasing tryptophan-derived indole metabolites (for example indole-3-lactic acid).
Those metabolites appeared to activate the aryl hydrocarbon receptor (AhR) pathway; BTWT’s benefit was reduced after antibiotic depletion of the microbiota and partially restored by fecal microbiota transplant. In vitro, indole-3-lactic acid reduced inflammation in an HT-29 cell model and increased AhR and CYP1A1/CYP1B1 expression.
BTWT is an herbal preparation tested preclinically in mice and cell systems; the abstract links its effects to microbiota-dependent changes in tryptophan metabolism and AhR activation but does not establish clinical efficacy or safety in humans. The report supports further mechanistic work on the AhR pathway as a therapeutic target for colitis.
Keep In Mind
This is an abstract-level report of experiments in mice and cell lines (basic science). It does not provide evidence of safety or efficacy in humans. Findings are mechanistic and hypothesis-generating; further work including clinical studies would be required before any treatment implications for people with IBD can be drawn.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationFood science & nutrition
AuthorsChun Niu, Yongli Hua, Jianguo Kang +4 more
InstitutionInstitute of Traditional Chinese Veterinary Medicine, College of Veterinary Medicine Gansu Agricultural University Lanzhou China.
Study typeJournal article
Indexed viaPubMed
Source typeResearch paper
PublishedOct 14, 2026, 12:00 AM
Content availableJournal abstract
Conflict statement: All authors stated that this study was not helped by any AI or AI‐related technologies.The authors declare no conflicts of interest.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
TNFAIP1 as a novel therapeutic target in ulcerative colitis and salidroside as its potential inhibitor.
The study identifies a previously unrecognized protein (TNFAIP1) that appears to promote inflammation in ulcerative colitis and proposes a compound (Salidroside) that directly binds and inhibits it in lab and mouse...
Metabolite 4-hydroxybenzoic acid, modulated by cigarette smoke exposure, functions as a protective factor in dextran sodium sulfate-induced colitis
This preclinical study suggests cigarette smoke alters gut microbes and metabolites in ways that can either protect or worsen colitis depending on the model; it identifies 4-HBA as a metabolite that reduced inflammation...
Endoplasmic reticulum stress in the logic of ulcerative colitis development
ER stress in intestinal epithelial cells is proposed as a key molecular mechanism in UC development; targeting ER pathways (notably IRE1β) could eventually lead to new treatments that strengthen the gut barrier and...